ROR1 (NTRKR1) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY Application EA-034081-B1 Eurasian Patent Organisation 25 Dec 2019
CD33 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY Grant EP-3126390-B1 European Patent Office 16 Oct 2019
CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BOTH ON IMMUNE CELLS AND… Application EP-3505623-A1 European Patent Office 03 Jul 2019
ROR1 (NTRKR1) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY Application EP-3453406-A1 European Patent Office 13 Mar 2019